EUVIMEDEUVIMED entdecken
Open Access

Long-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgery

Serdal Çelik, M Zeki Yalçın, Osman Kılıç, Mehmet Tan, Mahmet Tayyar Kalcioğlu

The Journal of International Advanced Otology · 2024

DOI: 10.5152/iao.2024.231208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of International Advanced Otology, 2024. Verfasst von Serdal Çelik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Istanbul Medeniyet University Faculty of Medicine, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Cholesteatoma, Middle Ear, Recurrence, Mesna, Mastoidectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although advanced technologies and surgical procedures are used, cholesteatoma is a disease with the possibility of recurrence. The aim of this study was to determine the long-term effect of sodium 2-mercaptoethane sulfonate (MESNA) on cholesteatoma surgery. METHODS: Patients who underwent cholesteatoma surgery between January 2009 and July 2014 by the same surgeon were divided into 2 groups: those where MESNA was used and those where it was not. Otomicroscopic examinations were performed to see the presence of cholesteatoma recurrence in the patients who had surgery at least 8 years ago. Pure-tone audiometry was performed to evaluate the hearing results. RESULTS: Sodium 2-mercaptoethane sulfonate was used in 23 patients and was not used in 39 patients who came to the control. In the MESNAused group, cholesteatoma was seen in only 1 of the patients who underwent a canal wall-down (CWD) mastoidectomy. In the MESNA non-used group, cholesteatoma was seen in 3 patients who underwent CWD. The difference was not statistically significant. CONCLUSION: Although there was no statistically significant difference, recurrence of cholesteatoma was seen less frequently in patients who received MESNA during surgery. Studies to be conducted in larger patient series may clarify this issue. Cite this article as: Celik S, Yalcın MZ, Kılıc O, Tan M, Kalcioglu MT. Long-term results of sodium 2-mercaptoethane sulfonate usage on cholesteatoma surgery. J Int Adv Otol. 2024;20(3):231-235.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesteatoma, Middle EarRecurrenceMesnaMastoidectomyHumansFemaleMaleAdultMiddle AgedTreatment OutcomeAudiometry, Pure-ToneAdolescentYoung AdultRetrospective StudiesAgedChild

Substanzen

Mesna

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Istanbul Medeniyet University Faculty of Medicine, İstanbul, Türkiye.
  • Göztepe Süleyman Yalçın City Hospital, Ear Nose Throat Clinic, İstanbul, Türkiye.
  • Department of Otorhinolaryngology, İnönü University Faculty of Medicine, Malatya, Türkiye.

Zitieren

APA

Çelik, S., Yalçın, M. Z., Kılıç, O., Tan, M., & Kalcioğlu, M. T. (2024). Long-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgery. The Journal of International Advanced Otology. https://doi.org/10.5152/iao.2024.231208

Vancouver

Çelik S, Yalçın MZ, Kılıç O, Tan M, Kalcioğlu MT. Long-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgery. The Journal of International Advanced Otology. 2024. doi:10.5152/iao.2024.231208

BibTeX
@article{elik2024,
  author = {Çelik, Serdal and Yalçın, M Zeki and Kılıç, Osman and Tan, Mehmet and Kalcioğlu, Mahmet Tayyar},
  title = {Long-Term Results of Sodium 2-Mercaptoethane Sulfonate Usage on Cholesteatoma Surgery},
  journal = {The Journal of International Advanced Otology},
  year = {2024},
  doi = {10.5152/iao.2024.231208}
}
Kostenlos starten →